loading

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
14.70%
361.63
315.27 264.71 240.76 216.31
Operating Income/Loss
14.70%
-361.63
-315.27 -264.71 -240.76 -216.31
Nonoperating Income/Loss
132.46%
-3.266
10.06 16.93 27.34 20.99
Income/Loss From Continuing Operations Before Tax
19.56%
-364.89
-305.21 -247.79 -213.42 -195.32
Income/Loss From Continuing Operations After Tax
19.56%
-364.89
-305.21 -247.79 -213.42 -194.57
Net Income/Loss
19.56%
-364.89
-305.21 -247.79 -213.42 -194.57
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.22%
1.4716
189.23 188.58 188.15 2.1613
Diluted Average Shares
99.22%
1.4716
189.23 188.58 188.15 2.1613
Basic Earnings Per Share
17.39%
-1.89
-1.61 -1.31 -1.13 -1.13
Diluted Earnings Per Share
17.39%
-1.89
-1.61 -1.31 -1.13 -1.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):